Sponsored Links

Anavex Advances Second Lead Compound; Initiates Scale-up Manufacturing Of ANAVEX 1-41 PDF Print E-mail
Medical News - Alzheimer's and Dementia
Anavex Life Sciences Corp., ("Anavex") (OTCBB: AVXL) today announced the initiation of scale-up manufacturing of ANAVEX 1-41, its lead compound for a range of important neurological diseases and a potential back-up compound to ANAVEX 2-73 in Alzheimer's disease. "This is an important step in the advancement of our second lead compound...

Read more: Alzheimer's / Dementia News From Medical News Today